West Pharmaceutical Services
3Q Revenues: $256.2 million (+6%)
3Q Earnings: $13.3 million (+9%)
YTD Revenues: $806.3 million (+6%)
YTD Earnings: $68.3 million (+5%)
Comments: Pharmaceutical systems segment sales were $190.5 million (+10%). Favorable currency translation contributed 4.7% points of that growth. Sales of traditional vial components, metal Flip-off seals, and safety and reconstitution products grew while prefillable syringe component sales declined due to a lower demand for ESA product packaging. Tech Group segment sales were $68.3 million in the quarter (-4%). Sales in 3Q07 included $7.3 million of sales of the discontinued Exubera device and $3.7 million of packaging for an OTC product.